Upcoming Webinars Archived Webinars Training Vitals Host A Webinar About Get Updates Contact

Alzheimer’s Diagnosis In Men Linked To Loss Of Y Chromosome

XTALKS VITALS NEWS

Alzheimer's

The researchers believe that the loss of Y could be a biomarker for Alzheimer’s, allowing physicians to diagnose the disease in its early stages.

Share this!

May 25, 2016 | by Sarah Massey, M.Sc.

A global research team has shown that men whose red blood cells are lacking a Y chromosome – a phenomenon known as loss of Y – may be more susceptible to developing Alzheimer’s. The researchers believe that the loss of Y could be a biomarker for Alzheimer’s, allowing physicians to diagnose the disease in its early stages.

The Y chromosome contains the genetic information necessary for many of the factors that make an individual physiologically male – including development of the testes - but in some men, their Y chromosome begins to degenerate as they age. As men tend to live shorter lives compared to women, and men are more likely to develop non-sex-linked cancers, this loss of Y may explain the differences in mortality between the sexes.

In order to investigate the potential link between loss of Y and Alzheimer’s, Professors Lars Forsberg and Jan Dumanski, from the Department of Immunology, Genetics, and Pathology at Uppsala University, Sweden, set up a collaboration with researchers in the UK, France, the US and Canada. Forsberg’s previous research interests included determining what effects the loss of the Y chromosome had on cancer development and progression.

“The idea for this research project came to me when I was writing our first paper on the relationship between loss of Y and the development of non-blood cancers,” said Forsberg. “In thinking about the process known as immunosurveillance - the body's ability to fight disease development throughout life - I found that it had been well studied in Alzheimer's disease, and hence it occurred to me that loss of Y might be involved in this disease too.”



The researchers studied the prevalence of Y chromosomes in the red blood cells of 3,300 men aged 37 to 96. Approximately 17 percent of the men showed a loss of Y in a minimum of 10 percent of their red blood cells.

The researchers found that elderly men more commonly displayed loss of Y. While the study contained a wide age range, the average age for study participants was 73.

Individuals with a pre-existing Alzheimer’s diagnosis were more likely to have a loss of Y. Interestingly, those identified as having a loss of Y were more likely to develop Alzheimer’s in the follow-up period after the study.

The researchers suggest that the degraded Y chromosome may lower the red blood cell’s ability to function during an immune response. Regardless, the researchers say that loss of Y could act as a biomarker to encourage physicians to begin neurological testing for Alzheimer’s.

More than 5 million people suffer from Alzheimer’s in the US alone; this number is expected to rise to 14 million by 2050.


Keywords: Alzheimer's, Cancer, Biomarker


| NEXT ARTICLE | MORE NEWS | BLOGS | VIDEOS | POLLS & QUIZZES | WEBINARS |

Share this with your colleagues!

MORE NEWS
Kite Pharma Secures FDA Approval for CAR-T Immunotherapy

October 20, 2017 - Kite Pharma’s Yescarta (axicabtagene ciloleucel) has become the second CAR-T immunotherapy to be approved in the US, with an indication in treating adult patients with relapsed or refractory large B-cell lymphoma.

Featured In: Biotech News


Fallopian Tubes Found to be Site of Origin for Most Ovarian Cancers

October 20, 2017 - This year, over 22,000 women will be diagnosed with ovarian cancer but a new study conducted by researchers at Perlmutter Cancer Center at NYU Langone Health suggests that most of these malignancies begin in another part of the reproductive system: the fallopian tubes.

Featured In: Life Science News


Food Companies are Looking for the Next Sriracha

October 19, 2017 - The Sriracha trend might be coming to an end and companies are looking for the next big hot sauce star to feature in their line-up.

Featured In: Food News


LEAVE A COMMENT
 
  
THE XTALKS VITALS INDUSTRY BLOG

Five Reasons Why Toronto is Emerging as a Major Life Sciences Hub

REGISTER FOR THESE WEBINARS

Brexit – Separating Fact from Fiction


Evolving Best Practices for Working with Authors of Scientific Publications – Authorship and Beyond


Human Whole-Genome Sequencing in a New Era Defined by the Illumina® HiSeq X® and NovaSeq™ Platforms


Clinical Event Adjudication: Comprehensive and Efficient Dossier Review Using a Global On-Line Solution


Copyright © 2016-2017 Honeycomb Worldwide Inc.